Citation tools
"Feasibility of Machine Learning-Assisted Personalized Dosimetry for Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia; a Phase III Clinical trial." Journal of Nuclear Medicine
62.supplement 1
(2021):
73.
Web. 18 April. 2024.